Pharmaceutical industry

Uncertainty over the future home of the EU’s drug regulator is impacting recruitment and staff motivation, director tells MEPs

Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the most part, that the cut is less than the €2.7B originally proposed

As the second tranche of projects in the €2 billion Innovative Medicines Initiative was announced this week, a quick stock take of progress to date hints at what this wide-ranging collaboration could deliver

UK pharmaceutical companies last year supported has nearly 14 per cent fewer PhD studentships and almost 25 per cent fewer postdoctoral grants than in 2003.

Without access to easy to use analysis tools, patents are becoming an expensive hindrance to many small companies, says Mick McLean, Head of Economics and Public Policy at Scientific Generics.